PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112524
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112524
Near-Infrared Imaging Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)
The global near-infrared imaging market was valued at USD 2.3 billion in 2025 and is projected to reach USD 3.3 billion by 2032, growing at a CAGR of 5.1% between 2026 and 2032. Growth is being driven by healthcare systems moving toward less invasive diagnostic and surgical techniques, as near-infrared imaging lets clinicians view tissues, blood vessels, and perfusion patterns in real time during procedures.
Cardiovascular disease burden underscores much of this demand. Cardiovascular disease deaths reached 19.2 million globally in 2023, according to the Institute for Health Metrics and Evaluation, a scale that keeps clinicians reliant on imaging tools that can evaluate perfusion and vessel visibility during procedures.
The market is also benefiting from steady improvements in imaging sensors, fluorescent agents, and portable device design, which are making near-infrared systems easier to integrate into operating rooms across hospitals, research laboratories, and emerging healthcare settings.
Key Insights
Reagents are both the largest and fastest-growing product category, at 60% share and approximately 5.3% CAGR, since imaging depends on repeated contrast agent use during surgical mapping and diagnostic imaging; an estimated 20 million new cancer cases occurred globally in 2025, according to the American Association for Cancer Research, sustaining steady reagent consumption.
Oncology is both the largest and fastest-growing indication, at 35% share and approximately 5.7% CAGR, as the technology helps clinicians distinguish malignant tissue and assess surgical margins; global cancer incidence reached 18.5 million new cases in 2023, excluding non-melanoma skin cancers, according to the Institute for Health Metrics and Evaluation.
Hospitals and Clinics are both the largest and fastest-growing end-user segment, at 40% share and approximately 5.5% CAGR, given high procedure volumes and access to advanced imaging infrastructure.
North America holds the largest regional share, at 40%, backed by early adoption of advanced imaging technologies and strong reimbursement systems. The U.S. saw over 2.0 million new cancer cases diagnosed in 2024, according to the American Cancer Society, sustaining continuous demand for advanced diagnostic imaging.
Asia-Pacific posts the highest regional CAGR, at approximately 6.0%, as hospitals across China, India, Japan, and South Korea expand access to advanced diagnostic and surgical technologies from a comparatively lower adoption base.
Japan holds a strong regional position given its aging population and precision healthcare focus; the population aged 65 and older reached 36.19 million in 2024, driving demand for precision imaging tools in complex, age-related surgical conditions.
India is seeing increasing adoption as private hospitals expand advanced surgical capabilities; 644,387 foreign tourists visited India for medical treatment in 2024, according to the Ministry of Tourism, supporting investment in internationally accredited hospitals with fluorescence-guided imaging.
Integration with surgical navigation systems is a defining trend, as real-time visualization lets surgeons evaluate tissue perfusion with greater precision. Sales of medical robots increased 91% to around 16,700 units globally in 2024, according to the International Federation of Robotics, while demand for surgical robots rose 41% the same year.
Rising demand for minimally invasive procedures remains the biggest driver. 173,727 organ transplants were performed globally in 2024, according to the Global Observatory on Donation and Transplantation, while 19.1 million non-surgical aesthetic procedures were performed worldwide in 2023, per the International Society of Aesthetic Plastic Surgery.
High equipment costs and limited accessibility are the main restraint, particularly for smaller hospitals and rural facilities; 3,455,100,410 people lived in rural areas globally in 2024, according to the World Bank, underscoring the scale of underserved settings that lack capital budgets for advanced imaging infrastructure.
Expansion of imaging use in surgical visualization presents a clear opportunity. Olympus Corporation launched its VISERA ELITE III surgical imaging platform in 2026 with fluorescence-guided surgery capabilities in full 4K, now available globally including in the United States across colorectal, gynecological, and hepatopancreatobiliary transplant surgery.
The competitive landscape remains fragmented across companies offering imaging systems, reagents, and integrated visualization software, differentiating through AI-enabled image analysis and compatibility with robotic-assisted platforms. Recent activity includes Leica Microsystems' 2026 introduction of the Viventis SCAPE light sheet microscope at Focus on Microscopy, made available globally through the company and its authorized partners.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Product
- 1.4.2. Market Size Breakdown, by Indication
- 1.4.3. Market Size Breakdown, by End User
- 1.4.4. Market Size Breakdown, by Region
- 1.4.5. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Sociopolitical Impact
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Bargaining Power of Buyers
- 5.4.2. Bargaining Power of Suppliers
- 5.4.3. Threat of New Entrants
- 5.4.4. Intensity of Rivalry
- 5.4.5. Threat of Substitutes
- 5.5. Lifecycle Analysis
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2025)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments by Key Players
- 6.6. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2021-2032)
- 7.3. Market Revenue, by Indication (2021-2032)
- 7.4. Market Revenue, by End User (2021-2032)
- 7.5. Market Revenue, by Region (2021-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2021-2032)
- 8.3. Market Revenue, by Indication (2021-2032)
- 8.4. Market Revenue, by End User (2021-2032)
- 8.5. Market Revenue, by Country (2021-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2021-2032)
- 9.3. Market Revenue, by Indication (2021-2032)
- 9.4. Market Revenue, by End User (2021-2032)
- 9.5. Market Revenue, by Country (2021-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2021-2032)
- 10.3. Market Revenue, by Indication (2021-2032)
- 10.4. Market Revenue, by End User (2021-2032)
- 10.5. Market Revenue, by Country (2021-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2021-2032)
- 11.3. Market Revenue, by Indication (2021-2032)
- 11.4. Market Revenue, by End User (2021-2032)
- 11.5. Market Revenue, by Country (2021-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2021-2032)
- 12.3. Market Revenue, by Indication (2021-2032)
- 12.4. Market Revenue, by End User (2021-2032)
- 12.5. Market Revenue, by Country (2021-2032)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Economic Indicators
- 13.3. Demographics and Population Insights
- 13.4. Growth Drivers
- 13.5. Challenges and Barriers
- 13.6. Competitive Strategies
- 13.7. Emerging Players
- 13.8. Market Size and Forecast
- 13.8.1. Market Revenue, by Product (2021-2032)
- 13.8.2. Market Revenue, by Indication (2021-2032)
- 13.8.3. Market Revenue, by End User (2021-2032)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Economic Indicators
- 14.3. Demographics and Population Insights
- 14.4. Growth Drivers
- 14.5. Challenges and Barriers
- 14.6. Competitive Strategies
- 14.7. Emerging Players
- 14.8. Market Size and Forecast
- 14.8.1. Market Revenue, by Product (2021-2032)
- 14.8.2. Market Revenue, by Indication (2021-2032)
- 14.8.3. Market Revenue, by End User (2021-2032)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Economic Indicators
- 15.3. Demographics and Population Insights
- 15.4. Growth Drivers
- 15.5. Challenges and Barriers
- 15.6. Competitive Strategies
- 15.7. Emerging Players
- 15.8. Market Size and Forecast
- 15.8.1. Market Revenue, by Product (2021-2032)
- 15.8.2. Market Revenue, by Indication (2021-2032)
- 15.8.3. Market Revenue, by End User (2021-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Economic Indicators
- 16.3. Demographics and Population Insights
- 16.4. Growth Drivers
- 16.5. Challenges and Barriers
- 16.6. Competitive Strategies
- 16.7. Emerging Players
- 16.8. Market Size and Forecast
- 16.8.1. Market Revenue, by Product (2021-2032)
- 16.8.2. Market Revenue, by Indication (2021-2032)
- 16.8.3. Market Revenue, by End User (2021-2032)
Chapter 17. France Market
- 17.1. Overview
- 17.2. Economic Indicators
- 17.3. Demographics and Population Insights
- 17.4. Growth Drivers
- 17.5. Challenges and Barriers
- 17.6. Competitive Strategies
- 17.7. Emerging Players
- 17.8. Market Size and Forecast
- 17.8.1. Market Revenue, by Product (2021-2032)
- 17.8.2. Market Revenue, by Indication (2021-2032)
- 17.8.3. Market Revenue, by End User (2021-2032)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Economic Indicators
- 18.3. Demographics and Population Insights
- 18.4. Growth Drivers
- 18.5. Challenges and Barriers
- 18.6. Competitive Strategies
- 18.7. Emerging Players
- 18.8. Market Size and Forecast
- 18.8.1. Market Revenue, by Product (2021-2032)
- 18.8.2. Market Revenue, by Indication (2021-2032)
- 18.8.3. Market Revenue, by End User (2021-2032)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Economic Indicators
- 19.3. Demographics and Population Insights
- 19.4. Growth Drivers
- 19.5. Challenges and Barriers
- 19.6. Competitive Strategies
- 19.7. Emerging Players
- 19.8. Market Size and Forecast
- 19.8.1. Market Revenue, by Product (2021-2032)
- 19.8.2. Market Revenue, by Indication (2021-2032)
- 19.8.3. Market Revenue, by End User (2021-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Economic Indicators
- 20.3. Demographics and Population Insights
- 20.4. Growth Drivers
- 20.5. Challenges and Barriers
- 20.6. Competitive Strategies
- 20.7. Emerging Players
- 20.8. Market Size and Forecast
- 20.8.1. Market Revenue, by Product (2021-2032)
- 20.8.2. Market Revenue, by Indication (2021-2032)
- 20.8.3. Market Revenue, by End User (2021-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Economic Indicators
- 21.3. Demographics and Population Insights
- 21.4. Growth Drivers
- 21.5. Challenges and Barriers
- 21.6. Competitive Strategies
- 21.7. Emerging Players
- 21.8. Market Size and Forecast
- 21.8.1. Market Revenue, by Product (2021-2032)
- 21.8.2. Market Revenue, by Indication (2021-2032)
- 21.8.3. Market Revenue, by End User (2021-2032)
Chapter 22. Japan Market
- 22.1. Overview
- 22.2. Economic Indicators
- 22.3. Demographics and Population Insights
- 22.4. Growth Drivers
- 22.5. Challenges and Barriers
- 22.6. Competitive Strategies
- 22.7. Emerging Players
- 22.8. Market Size and Forecast
- 22.8.1. Market Revenue, by Product (2021-2032)
- 22.8.2. Market Revenue, by Indication (2021-2032)
- 22.8.3. Market Revenue, by End User (2021-2032)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Economic Indicators
- 23.3. Demographics and Population Insights
- 23.4. Growth Drivers
- 23.5. Challenges and Barriers
- 23.6. Competitive Strategies
- 23.7. Emerging Players
- 23.8. Market Size and Forecast
- 23.8.1. Market Revenue, by Product (2021-2032)
- 23.8.2. Market Revenue, by Indication (2021-2032)
- 23.8.3. Market Revenue, by End User (2021-2032)
Chapter 24. Australia Market
- 24.1. Overview
- 24.2. Economic Indicators
- 24.3. Demographics and Population Insights
- 24.4. Growth Drivers
- 24.5. Challenges and Barriers
- 24.6. Competitive Strategies
- 24.7. Emerging Players
- 24.8. Market Size and Forecast
- 24.8.1. Market Revenue, by Product (2021-2032)
- 24.8.2. Market Revenue, by Indication (2021-2032)
- 24.8.3. Market Revenue, by End User (2021-2032)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Economic Indicators
- 25.3. Demographics and Population Insights
- 25.4. Growth Drivers
- 25.5. Challenges and Barriers
- 25.6. Competitive Strategies
- 25.7. Emerging Players
- 25.8. Market Size and Forecast
- 25.8.1. Market Revenue, by Product (2021-2032)
- 25.8.2. Market Revenue, by Indication (2021-2032)
- 25.8.3. Market Revenue, by End User (2021-2032)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Economic Indicators
- 26.3. Demographics and Population Insights
- 26.4. Growth Drivers
- 26.5. Challenges and Barriers
- 26.6. Competitive Strategies
- 26.7. Emerging Players
- 26.8. Market Size and Forecast
- 26.8.1. Market Revenue, by Product (2021-2032)
- 26.8.2. Market Revenue, by Indication (2021-2032)
- 26.8.3. Market Revenue, by End User (2021-2032)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Economic Indicators
- 27.3. Demographics and Population Insights
- 27.4. Growth Drivers
- 27.5. Challenges and Barriers
- 27.6. Competitive Strategies
- 27.7. Emerging Players
- 27.8. Market Size and Forecast
- 27.8.1. Market Revenue, by Product (2021-2032)
- 27.8.2. Market Revenue, by Indication (2021-2032)
- 27.8.3. Market Revenue, by End User (2021-2032)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Economic Indicators
- 28.3. Demographics and Population Insights
- 28.4. Growth Drivers
- 28.5. Challenges and Barriers
- 28.6. Competitive Strategies
- 28.7. Emerging Players
- 28.8. Market Size and Forecast
- 28.8.1. Market Revenue, by Product (2021-2032)
- 28.8.2. Market Revenue, by Indication (2021-2032)
- 28.8.3. Market Revenue, by End User (2021-2032)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Economic Indicators
- 29.3. Demographics and Population Insights
- 29.4. Growth Drivers
- 29.5. Challenges and Barriers
- 29.6. Competitive Strategies
- 29.7. Emerging Players
- 29.8. Market Size and Forecast
- 29.8.1. Market Revenue, by Product (2021-2032)
- 29.8.2. Market Revenue, by Indication (2021-2032)
- 29.8.3. Market Revenue, by End User (2021-2032)
Chapter 30. Company Profiles
Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
